Therapeutic Peptides: Recent Advances in Discovery, Synthesis, and Clinical Translation DOI Open Access

Bingyi Zheng,

Xueting Wang, Minzhe Guo

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(11), С. 5131 - 5131

Опубликована: Май 27, 2025

In recent decades, peptide-based therapeutics have undergone transformative advancements driven by breakthroughs in production, modification, and analytical technologies. Innovations chemical biological synthesis, coupled with novel design delivery strategies, systematically addressed historical limitations (e.g., poor stability bioavailability). These facilitated the characterization clinical translation of diverse natural engineered peptides across therapeutic domains, including metabolic disorders, oncology, infectious diseases. This review synthesizes critical developments peptide drug discovery, production technologies, applications, while highlighting emerging challenges opportunities. We further evaluate potential addressing unmet medical needs propose strategic directions to accelerate their integration into precision medicine paradigms.

Язык: Английский

Antimicrobial Activity of the Peptide C14R Against Ab Initio Growing and Preformed Biofilms of Candida albicans, Candidaparapsilosis and Candidozyma auris DOI Creative Commons

John B. Walter,

Ann‐Kathrin Kissmann,

DORINNE KAN GRUBER

и другие.

Biomolecules, Год журнала: 2025, Номер 15(3), С. 322 - 322

Опубликована: Фев. 21, 2025

Biofilms are the predominant lifeforms of microorganisms, contributing to over 80% infections, including those caused by Candida species like C. albicans, parapsilosis and Candidozyma auris. These form biofilms on medical devices, making infections challenging treat, especially with rise in drug-resistant strains. particularly hospital-acquired ones, a significant health threat due their resistance antifungals risk developing systemic (i.e., sepsis). We have previously shown that C14R reduces viability albicans auris, but not parapsilosis. Here, we show only inhibits pore formation, resazurin reduction assay, fluorescence-based permeabilization it also halts biofilm maturation significantly biomass preformed 70%. findings suggest could be an effective option for treating severe fungal offering potential new treatment approach biofilm-related diseases. Further research is needed fully understand its dispersal optimize use future applications as antifungal clinical settings.

Язык: Английский

Процитировано

1

Anti-Staphylococcus aureus Activity and Structural Characterization of Rationally Designed Peptides DOI Creative Commons
Lorenza Artesani, Mariana Gallo, Laura Giovati

и другие.

Antibiotics, Год журнала: 2025, Номер 14(5), С. 437 - 437

Опубликована: Апрель 26, 2025

Background/Objectives: Microbial infections represent a significant threat to public health due the emergence and spread of antimicrobial resistance. Adjunctive alternative therapeutic strategies are explored tackle this issue, including use natural or synthetic peptides. Previous research showed that antibody-derived peptides possess antimicrobial, antiviral, immunomodulatory properties. This study aimed characterize newly designed evaluate their effectiveness against representative strains Staphylococcus aureus, drug-resistant isolates. Methods: Colony-forming unit assays confocal microscopy studies were performed peptide activity planktonic microbial cells. Cytotoxicity tests on THP-1 human monocytic Circular dichroism (CD) nuclear magnetic resonance (NMR) employed for conformational characterization Results: The half-maximal effective concentrations bacterial reference isolates ranged from 0.17 18.05 µM, while cytotoxic effects not observed mammalian A killing kinetics analysis observation by interaction between bacteria suggested mechanism action involving membrane perturbation. CD all predominantly exhibit random coil arrangement in aqueous solution. NMR spectroscopy revealed most active adopts helical conformation presence mimetics. Conclusions: structural evaluation peptides' may lead selection candidate be further studied develop an treatment caused strains.

Язык: Английский

Процитировано

0

Therapeutic Peptides: Recent Advances in Discovery, Synthesis, and Clinical Translation DOI Open Access

Bingyi Zheng,

Xueting Wang, Minzhe Guo

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(11), С. 5131 - 5131

Опубликована: Май 27, 2025

In recent decades, peptide-based therapeutics have undergone transformative advancements driven by breakthroughs in production, modification, and analytical technologies. Innovations chemical biological synthesis, coupled with novel design delivery strategies, systematically addressed historical limitations (e.g., poor stability bioavailability). These facilitated the characterization clinical translation of diverse natural engineered peptides across therapeutic domains, including metabolic disorders, oncology, infectious diseases. This review synthesizes critical developments peptide drug discovery, production technologies, applications, while highlighting emerging challenges opportunities. We further evaluate potential addressing unmet medical needs propose strategic directions to accelerate their integration into precision medicine paradigms.

Язык: Английский

Процитировано

0